Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous?

Ann Rheum Dis. 1999 Jul;58(7):392-5. doi: 10.1136/ard.58.7.392.

Authors

M T Nurmohamed¹, W F Lems, B A Dijkmans

Affiliation

¹ Department of Rheumatology, Slotervaart Hospital and Jan van Breemen Institute, Amsterdam, the Netherlands.

No abstract available

Publication types

Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / surgery*
Arthroplasty, Replacement*
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Aspirin / therapeutic use
Drug Administration Schedule
Fibrinolytic Agents / administration & dosage*
Fibrinolytic Agents / therapeutic use
Humans
Osteoarthritis / complications
Osteoarthritis / surgery
Postoperative Complications / prevention & control*
Risk
Thromboembolism / prevention & control*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Fibrinolytic Agents
Aspirin